SDC1 and myocardial infarction: In trauma patients and patients with acute myocardial infarction, high levels of circulating syndecan-1, a transmembrane endothelial proteoglycan and a marker of endothelial glycocalyx degradation (Pries et al., 2000), is associated with inflammation, coagulopathy, and increased mortality (Johansson et al., 2011; Ostrowski et al., 2013a,b).